Altered serum levels of cytokines in patients with myasthenia gravis
Background: Myasthenia gravis (MG) is an autoimmune disease characterized by generalized skeletal muscle contraction weakness due to autoantibodies targeting neural-muscular junctions. Here, we investigated the relationship between key cytokines and MG type, disease course, antibodies, and comorbidi...
Main Authors: | Shu-Li Wei, Chun-Lin Yang, Wei-Yue Si, Jing Dong, Xue-Lu Zhao, Peng Zhang, Heng Li, Cong-Cong Wang, Min Zhang, Xiao-Li Li, Rui-Sheng Duan |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-01-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844023109534 |
Similar Items
-
Immunological and Structural Characterization of Titin Main Immunogenic Region; I110 Domain Is the Target of Titin Antibodies in Myasthenia Gravis
by: Christos Stergiou, et al.
Published: (2023-02-01) -
Fetal Surveillance in Pregnancies with Myasthenia Gravis
by: Brîndușa Ana Cimpoca-Raptis, et al.
Published: (2021-11-01) -
Myasthenia gravis and related disorders : 11th International Conference /
by: Kaminski, Henry J., et al.
Published: (2008) -
Targeted treatment approaches and pathogenicity of antibody subclasses in MuSK-myasthenia gravis
by: Cao, M
Published: (2021) -
Clinical characteristics of late-onset myasthenia gravis
by: Chenjing Sun, et al.
Published: (2024-04-01)